Concepedia

Physiologically-based pharmacokinetic modeling-guided rational combination of tacrolimus and voriconazole in patients with different CYP3A5 and CYP2C19 alleles

Fei Gong, Huihui Hu, Ying Ouyang, Zhengzheng Liao, Ying Kong, Jinfang Hu, Hua He, Ying Zhou

Toxicology and Applied Pharmacology · 2023 · 11 citations · 42 references

DOI

Concepts

References

42

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for <i>CYP3A5</i> Genotype and Tacrolimus Dosing

Brian S. Decker, JM Barbarino, JF Peterson et al. · Clinical Pharmacology & Therapeutics · 2015 · 692 citations · Full text

, , +17

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

Dennis A. Hesselink · Clinical Pharmacology & Therapeutics · 2003 · 653 citations

, , +17

Man versus Beast: Pharmacokinetic Scaling in Mammals

Joyce Mordenti · Journal of Pharmaceutical Sciences · 1986 · 390 citations

, , +12

General approach for the calculation of tissue to plasma partition coefficients

Walter Schmitt · Toxicology in Vitro · 2007 · 354 citations

, , +8

Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children

Andrea N. Edginton, Walter Schmitt, Stefan Willmann · Clinical Pharmacokinetics · 2006 · 354 citations

, , +13